The role of cardiotrophin-1 and annexin V in myocardial remodelling of spontaneous hypertensive rats with experimental diabetes mellitus.

Authors

  • M. Yu. Kolesnyk Запорожский государственный медицинский университет, Запорожье, Ukraine

DOI:

https://doi.org/10.26641/1997-9665.2013.3.60-64

Keywords:

cardiotrophin-1, annexin V, myocardium, experimental diabetes mellitus, spontaneous hypertensive rats

Abstract

Background. Сardiotrophin-1 is thought to be one of the key regulator of cardiac hypertrophy and hyperplasia, and has influence on apoptosis intensity and sensitivity to ischemia. Objective. The aim of the investigation was to study the role of cardiotrophin-1 in pathological myocardial remodeling in arterial hypertension with diabetes. Methods. Spontaneous hypertensive rats with experimental diabetes were used in the study. The expression of cardiotrophin-1 was analyzed by immunohystochemical method. Apoptitic cells were confirmed by annexin V detection. Results. It was found that cardiac content of cardiotrophin-1 was 2.6-fold higher in myocardium of hypertensive rats with diabetes in comparison with rats without diabetes. The concentration of annexin V was slightly increased in animals with experimental diabetes. Conclusion. The high content of cardiotrophin-1 in hypertension with diabetes is thought to be the factor which decreases the intensity of caridomyocytes’ apoptosis.

References

  1. Calabrò P, Limongelli G, Riegler L, Maddaloni V, Palmieri R, Golia E, Roselli T, Masarone D, Pacileo G, Golino P, Calabrò R. Novel insights into the role of cardiotrophin-1 in cardiovascular diseases. J Mol Cell Cardiol. 2009 Feb;46 (2): 142-8. doi: 10.1016/j.yjmcc.2008.11.002. Epub 2008 Nov 13. Cited in: PubMed; PMID: 19059413.
  2. Jougasaki M. Cardiotrophin-1 in cardiovascular regulation. Adv Clin Chem. 2010; 52: 41-76. Cited in: PubMed; PMID: 21275339.
  3. Stejskal D, Ruzicka V. Cardiotrophin-1. Review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008 Jun;152(1):9-19. Cited in: PubMed; PMID: 18795069.
  4. López N, Díez J, Fortuño MA. Characterization of the protective effects of cardiotrophin-1 against non-ischemic death stimuli in adult cardiomyocytes. Cytokine. 2005 Jun 7;30(5):282-92. Cited in: PubMed; PMID: 15927854.
  5. Robador PA, San José G, Rodríguez C, Guadall A, Moreno MU, Beaumont J, Fortuño A, Díez J, Martínez-González J, Zalba G. HIF-1-mediated up-regulation of cardiotrophin-1 is involved in the survival response of cardiomyocytes to hypoxia. Cardiovasc Res. 2011 Nov 1;92(2):247-55. doi: 10.1093/cvr/cvr202. Epub 2011 Jul 19. Cited in: PubMed; PMID: 21771897.
  6. Ravassa S, Fortuño MA, González A, López B, Zalba G, Fortuño A, Díez J. Mechanisms of increased susceptibility to angiotensin II-induced apoptosis in ventricular cardiomyocytes of hypertensive rats. Hypertension. 2000 Dec;36(6):1065-71. Cited in: PubMed; PMID: 11116126.
  7. Toh R, Kawashima S, Kawai M, Sakoda T, Ueyama T, Satomi-Kobayashi S, Hirayama S, Yokoyama M. Transplantation of cardiotrophin-1-expressing myoblasts to the left ventricular wall alleviates the transition from compensatory hypertrophy to congestive heart failure in Dahl salt-sensitive hypertensive rats. J Am Coll Cardiol. 2004 Jun 16;43(12):2337-47. Cited in: PubMed; PMID: 15193703.
  8. Pemberton CJ, Raudsepp SD, Yandle TG, Cameron VA, Richards AM. Plasma cardiotrophin-1 is elevated in human hypertension and stimulated by ventricular stretch. Cardiovasc Res. 2005 Oct 1;68(1):109-17. Cited in: PubMed; PMID: 15978561.
  9. López-Andrés N, Calvier L, Labat C, Fay R, Díez J, Benetos A, Zannad F, Lacolley P, Rossignol P. Absence of cardiotrophin 1 is associated with decreased age-dependent arterial stiffness and increased longevity in mice. Hypertension. 2013 Jan;61(1):120-9. doi:
  10. 1161/HYPERTENSIONAHA.112.201699. Epub 2012 Nov 19. Cited in: PubMed; PMID: 23172930.
  11. Ravassa S, Beloqui O, Varo N, Barba J, López B, Beaumont J, Zalba G, Díez J, González A. Association of cardiotrophin-1 with left ventricular systolic properties in asymptomatic hypertensive patients. J Hypertens. 2013 Mar;31(3):587-94. doi: 10.1097/HJH.0b013e32835ca903. Cited in: PubMed; PMID: 23429662.
  12. Ares-Carrasco S, Picatoste B, Benito-Martín A, Zubiri I, Sanz AB, Sánchez-Niño MD, Ortiz A, Egido J, Tuñón J, Lorenzo O. Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes. Am J Physiol Heart Circ Physiol. 2009 Dec;297(6):H2109-19. doi: 10.1152/ajpheart.00157.2009. Epub 2009 Oct 9. Cited in: PubMed; PMID: 19820199.

Downloads

How to Cite

Kolesnyk, M. Y. (2013). The role of cardiotrophin-1 and annexin V in myocardial remodelling of spontaneous hypertensive rats with experimental diabetes mellitus. Морфологія / Morphologia / Morfologìâ, 7(3), 60–64. https://doi.org/10.26641/1997-9665.2013.3.60-64

Issue

Vol. 7 No. 3 (2013)

Section

Статті

License

Copyright (c) 2018 Morphologia

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

 The authors reserve the right to authorship of their work and transfer to the Journal the right to the first publication of this work under the terms of a license Creative commons Attribution 4.0 International (CC BY 4.0), which allows other people to freely distribute the published work with a mandatory reference to the authors of the original work and the first publication of the work in this journal.
        By submitting a manuscript to the editorial office of the Journal ‘Morphologia’ authors agree to transfer the rights to protect and use the manuscript (all supplemental materials, particularly protected objects such as photos, drawings, diagrams, tables, etc.), including the reproduction in the press and distribution via the Internet; translation of the manuscript into any language; export and import of journal copies with the Authors’ article in order to make it available for public. Authors convey the rights mentioned above to the editorial office without any temporal or territorial limitation all over the world. 
        The Authors guarantee that they have the exclusive rights to use the material transferred to editorial office. Editors are not responsible to third parties for contraventions of warranty given by the Authors. The considered rights are transferred to the editorial office since the moment when the current issue is signed for publishing. Reproduction of materials published in the Journal by other individuals and legal entities is possible only with the consent of Editorial office, with the obligatory indication of the full bibliographic reference of the primary publication. The Authors reserve the right to use the published material, its fragments and parts for teaching materials, oral presentations, dissertation thesis prepararion with obligatory bibliographic citation of the original paper. Electron copy of the published article, downloaded from official journal web-site in .pdf format may be put by authors on the official web-site of their institutions, any other official resources with open access.